Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: GABAergic synapse (mmu04727)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
AK157575
KLA  ATP  ATP+KLA
 AK157575 activated spleen cDNA, RIKEN full-length enriched library, clone:F830224H04 product:unclassifiable, full insert sequence. [AK157575] KLA .73 .72 .68 .76 .91 .91 1.02
ATP 2.85 3.50 5.51 5.90 1.67 .96 .94
KLA/ATP 1.11 1.56 2.49 2.64 1.45 1.05 .95
Abat
KLA  ATP  ATP+KLA
 AK083062 12 days embryo spinal cord cDNA, RIKEN full-length enriched library, clone:C530041H11 product:hypothetical protein, full insert sequence. [AK083062] KLA 1.01 1.09 .97 .99 1.03 1.02 1.06
ATP .96 .99 1.00 1.11 1.04 .98 1.06
KLA/ATP 1.06 1.03 .96 1.06 1.10 1.06 .96
Abat
KLA  ATP  ATP+KLA
 NM_172961 4-aminobutyrate aminotransferase (Abat), nuclear gene encoding mitochondrial protein, mRNA [NM_172961] KLA 1.03 .96 .97 1.00 .92 .97 .96
ATP .97 .93 1.07 1.04 .97 .99 .98
KLA/ATP 1.03 1.01 1.00 .98 .94 .89 .97
Adcy1
KLA  ATP  ATP+KLA
 BC050125 adenylate cyclase 1, mRNA (cDNA clone IMAGE:30015692). [BC050125] KLA 1.05 1.03 .98 1.04 1.05 1.09 1.10
ATP .90 1.02 .99 .97 1.03 .95 1.01
KLA/ATP .99 1.04 .90 .98 .98 1.00 1.03
Adcy1
KLA  ATP  ATP+KLA
 NM_009622 adenylate cyclase 1 (Adcy1), mRNA [NM_009622] KLA 1.07 1.02 1.06 1.07 1.03 1.02 1.01
ATP 1.02 1.04 1.00 .99 .99 .95 .97
KLA/ATP .97 1.05 1.02 1.05 1.01 .98 1.05
Adcy2
KLA  ATP  ATP+KLA
 NM_153534 adenylate cyclase 2 (Adcy2), mRNA [NM_153534] KLA .79 .82 .83 .73 .61 .66 .90
ATP 1.10 1.09 1.02 1.04 .88 .58 .53
KLA/ATP .84 .87 .77 .75 .68 .60 .43
Adcy3
KLA  ATP  ATP+KLA
 NM_138305 adenylate cyclase 3 (Adcy3), mRNA [NM_138305] KLA .84 .84 .83 .78 .66 .55 .49
ATP 1.09 1.05 .89 1.02 .84 .62 1.52
KLA/ATP .93 .87 .75 .85 .66 .83 .77
Adcy4
KLA  ATP  ATP+KLA
 NM_080435 adenylate cyclase 4 (Adcy4), mRNA [NM_080435] KLA 1.05 1.07 .96 1.00 1.04 1.05 1.05
ATP 1.02 1.05 1.02 1.48 1.37 1.08 1.09
KLA/ATP 1.00 1.05 .91 1.19 1.35 1.27 1.08
Adcy5
KLA  ATP  ATP+KLA
 NM_001012765 adenylate cyclase 5 (Adcy5), mRNA [NM_001012765] KLA 1.06 1.00 .97 1.01 1.03 .95 .93
ATP .95 1.08 1.08 1.07 .97 1.03 .97
KLA/ATP .97 .92 1.04 .99 .91 .96 1.04
Adcy6
KLA  ATP  ATP+KLA
 NM_007405 adenylate cyclase 6 (Adcy6), mRNA [NM_007405] KLA 1.10 1.16 1.16 1.09 1.08 1.06 .99
ATP 1.05 .97 1.08 1.12 1.08 1.08 1.04
KLA/ATP 1.14 1.20 1.29 1.30 1.25 1.11 1.07
Adcy7
KLA  ATP  ATP+KLA
 NM_001037724 adenylate cyclase 7 (Adcy7), transcript variant 3, mRNA [NM_001037724] KLA .43 .39 .35 .32 .45 .72 .84
ATP .90 .84 .62 .41 .53 .42 .94
KLA/ATP .39 .34 .23 .17 .41 .34 .67
Adcy7
KLA  ATP  ATP+KLA
 NM_007406 adenylate cyclase 7 (Adcy7), transcript variant 1, mRNA [NM_007406] KLA .51 .52 .48 .41 .59 .81 .99
ATP 1.01 1.02 .62 .52 .53 .38 .98
KLA/ATP .53 .48 .30 .27 .42 .36 .65
Adcy8
KLA  ATP  ATP+KLA
 NM_009623 adenylate cyclase 8 (Adcy8), mRNA [NM_009623] KLA 1.00 1.00 1.07 .97 1.04 .98 1.02
ATP 1.04 1.05 1.14 1.03 .99 1.00 .97
KLA/ATP 1.05 1.04 1.00 1.03 .98 .94 .96
Adcy9
KLA  ATP  ATP+KLA
 NM_009624 adenylate cyclase 9 (Adcy9), mRNA [NM_009624] KLA .18 .15 .13 .15 .17 .19 .33
ATP 1.33 1.16 .97 .98 .62 .56 .86
KLA/ATP .19 .16 .17 .18 .20 .25 .38
Cacna1a
KLA  ATP  ATP+KLA
 NM_007578 calcium channel, voltage-dependent, P/Q type, alpha 1A subunit (Cacna1a), mRNA [NM_007578] KLA .71 .66 .61 .63 .60 .71 .72
ATP 1.07 1.04 .89 1.08 .71 .56 .75
KLA/ATP .71 .72 .85 .69 .64 .63 .68
Cacna1b
KLA  ATP  ATP+KLA
 U04999 N-type calcium channel alpha1 subunit mRNA, complete cds [U04999] KLA .94 .94 .95 .88 1.09 .85 .92
ATP 1.06 1.17 1.00 1.24 1.59 1.15 1.17
KLA/ATP .91 .91 .95 .95 .90 .97 1.01
Cacna1d
KLA  ATP  ATP+KLA
 NM_001083616 calcium channel, voltage-dependent, L type, alpha 1D subunit (Cacna1d), transcript variant 2, mRNA [NM_001083616] KLA 1.57 1.58 2.50 3.62 4.55 2.93 .99
ATP 1.12 .99 .97 .94 .75 1.71 1.48
KLA/ATP 1.47 1.51 1.82 1.56 1.67 2.93 4.60
Cacna1d
KLA  ATP  ATP+KLA
 NM_028981 calcium channel, voltage-dependent, L type, alpha 1D subunit (Cacna1d), transcript variant 1, mRNA [NM_028981] KLA 1.20 1.26 1.43 1.62 2.07 1.66 1.00
ATP 1.03 1.03 .97 .97 .93 1.20 1.26
KLA/ATP 1.16 1.12 1.10 1.14 1.08 1.44 2.56
Cacna1f
KLA  ATP  ATP+KLA
 NM_019582 calcium channel, voltage-dependent, alpha 1F subunit (Cacna1f), mRNA [NM_019582] KLA 1.03 .98 1.05 1.06 1.00 1.02 1.01
ATP 1.05 1.05 .95 .98 .97 .96 1.01
KLA/ATP 1.01 1.03 .94 1.01 1.01 1.00 .99
Cacna1s
KLA  ATP  ATP+KLA
 NM_001081023 calcium channel, voltage-dependent, L type, alpha 1S subunit (Cacna1s), mRNA [NM_001081023] KLA 1.03 1.01 .96 1.06 1.00 1.00 1.05
ATP 1.01 .98 1.02 1.02 1.05 1.07 1.05
KLA/ATP .99 1.05 1.02 1.05 1.03 1.05 1.00
Gabarap
KLA  ATP  ATP+KLA
 NM_019749 gamma-aminobutyric acid receptor associated protein (Gabarap), mRNA [NM_019749] KLA .93 .88 .95 .99 1.07 1.06 1.22
ATP 1.22 1.27 .95 1.38 1.44 1.25 1.51
KLA/ATP 1.02 1.11 .86 1.30 1.17 1.49 2.13
Gabarapl
1
KLA  ATP  ATP+KLA
 NM_020590 gamma-aminobutyric acid (GABA(A)) receptor-associated protein-like 1 (Gabarapl1), mRNA [NM_020590] KLA .68 .67 .64 .55 .50 .58 .81
ATP 1.03 1.09 1.28 1.46 3.14 3.86 .91
KLA/ATP .69 .75 .80 .92 1.74 2.32 1.07
Gabarapl
2
KLA  ATP  ATP+KLA
 AK049819 adult male hippocampus cDNA, RIKEN full-length enriched library, clone:C630001N14 product:GABA(A) receptor-associated protein like 2, full insert sequence [AK049819] KLA .92 .94 .93 .95 .85 .85 .86
ATP .98 1.03 1.17 1.18 1.19 1.04 .86
KLA/ATP .98 1.04 1.09 1.03 1.06 .91 .87
Gabbr1
KLA  ATP  ATP+KLA
 NM_019439 gamma-aminobutyric acid (GABA-B) receptor, 1 (Gabbr1), mRNA [NM_019439] KLA 1.00 1.03 1.04 1.01 .97 1.01 .99
ATP .98 .96 1.03 1.01 .96 1.03 .99
KLA/ATP .97 1.00 .97 1.02 1.02 .97 1.01
Gabbr2
KLA  ATP  ATP+KLA
 NM_001081141 gamma-aminobutyric acid (GABA) B receptor 2 (Gabbr2), mRNA [NM_001081141] KLA 1.06 .98 .99 1.03 1.09 1.06 1.02
ATP 1.03 1.06 1.05 1.14 1.10 1.00 1.04
KLA/ATP 1.09 1.10 1.12 1.11 1.06 1.04 1.06
Gabra1
KLA  ATP  ATP+KLA
 NM_010250 gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 1 (Gabra1), mRNA [NM_010250] KLA 1.01 .99 1.01 1.06 1.00 1.07 1.04
ATP 1.03 1.04 1.07 1.05 1.02 .99 .99
KLA/ATP 1.05 1.02 1.04 1.06 1.05 1.06 1.01
Gabra2
KLA  ATP  ATP+KLA
 AK048165 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130038H23 product:gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 2, full insert sequence [AK048165] KLA .98 1.06 1.03 1.01 1.03 1.03 .98
ATP 1.00 1.00 1.05 1.07 .96 .92 1.04
KLA/ATP 1.02 1.09 .97 1.02 .99 .98 .80
Gabra2
KLA  ATP  ATP+KLA
 NM_008066 gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 2 (Gabra2), mRNA [NM_008066] KLA .99 1.01 1.10 1.05 .96 .93 .98
ATP 1.09 .99 .99 .98 .97 .93 .94
KLA/ATP .99 .97 .97 .96 1.02 .97 1.04
Gabra3
KLA  ATP  ATP+KLA
 NM_008067 gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 (Gabra3), mRNA [NM_008067] KLA 1.00 1.01 1.03 .99 1.01 1.00 1.01
ATP 1.03 .97 1.03 .98 .98 .97 1.00
KLA/ATP .99 1.08 1.05 .98 1.00 1.03 .96
Gabra4
KLA  ATP  ATP+KLA
 NM_010251 gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 (Gabra4), mRNA [NM_010251] KLA .98 1.01 1.02 .99 1.03 .95 1.02
ATP .98 .94 1.03 1.09 1.00 1.06 1.03
KLA/ATP 1.04 1.00 1.02 .97 1.02 1.05 .98
Gabra5
KLA  ATP  ATP+KLA
 NM_176942 gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 (Gabra5), mRNA [NM_176942] KLA .97 .92 1.00 .97 1.01 .99 .97
ATP 1.02 .99 1.03 .98 1.00 .98 1.00
KLA/ATP .97 .99 1.01 1.00 .97 .97 .92
Gabra6
KLA  ATP  ATP+KLA
 NM_008068 gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 (Gabra6), transcript variant 2, mRNA [NM_008068] KLA 1.05 1.02 .96 1.06 .96 1.02 1.07
ATP 1.01 .96 1.03 1.00 .99 .94 1.07
KLA/ATP .99 .99 1.09 1.01 1.13 .97 1.07
Gabrb1
KLA  ATP  ATP+KLA
 NM_008069 gamma-aminobutyric acid (GABA-A) receptor, subunit beta 1 (Gabrb1), mRNA [NM_008069] KLA .99 .98 .99 1.00 1.02 .99 .95
ATP 1.00 1.04 .98 1.01 1.05 1.02 1.03
KLA/ATP 1.00 .96 1.00 .96 1.05 1.03 1.04
Gabrb2
KLA  ATP  ATP+KLA
 NM_008070 gamma-aminobutyric acid (GABA-A) receptor, subunit beta 2 (Gabrb2), mRNA [NM_008070] KLA 1.04 1.04 1.03 1.04 1.00 .98 1.03
ATP .99 1.01 1.00 1.01 1.03 .99 .93
KLA/ATP 1.05 1.06 1.05 .96 .97 .94 1.00
Gabrb3
KLA  ATP  ATP+KLA
 NM_008071 gamma-aminobutyric acid (GABA-A) receptor, subunit beta 3 (Gabrb3), transcript variant 1, mRNA [NM_008071] KLA .99 .99 .99 1.01 .99 .97 1.00
ATP .98 1.02 1.00 .99 .99 .99 1.00
KLA/ATP 1.00 1.03 1.05 .97 .98 .99 .99
Gabrd
KLA  ATP  ATP+KLA
 NM_008072 gamma-aminobutyric acid (GABA-A) receptor, subunit delta (Gabrd), mRNA [NM_008072] KLA 1.36 1.25 1.30 1.25 1.16 1.42 1.07
ATP .97 .82 .91 .80 .74 1.02 .96
KLA/ATP 1.12 1.10 1.06 .87 .89 1.04 1.12
Gabre
KLA  ATP  ATP+KLA
 NM_017369 gamma-aminobutyric acid (GABA-A) receptor, subunit epsilon (Gabre), mRNA [NM_017369] KLA .97 1.04 .98 1.01 1.03 .99 1.05
ATP .96 1.00 .96 1.04 .98 .99 1.02
KLA/ATP 1.00 1.02 1.01 .97 .93 .93 .89
Gabrg1
KLA  ATP  ATP+KLA
 AK038686 adult male hypothalamus cDNA, RIKEN full-length enriched library, clone:A230055A07 product:gamma-aminobutyric acid (GABA-A) receptor, subunit gamma 1, full insert sequence. [AK038686] KLA .98 1.06 1.09 1.00 1.01 1.05 1.07
ATP .96 .99 1.03 1.03 1.03 1.00 1.08
KLA/ATP 1.04 1.04 .90 1.04 1.04 1.08 1.07
Gabrg1
KLA  ATP  ATP+KLA
 NM_010252 gamma-aminobutyric acid (GABA-A) receptor, subunit gamma 1 (Gabrg1), mRNA [NM_010252] KLA 1.00 1.00 .98 .99 1.01 1.01 1.01
ATP 1.00 .99 1.00 1.03 1.01 1.02 1.01
KLA/ATP .98 .98 1.00 1.00 1.00 1.00 1.02
Gabrg2
KLA  ATP  ATP+KLA
 NM_008073 gamma-aminobutyric acid (GABA-A) receptor, subunit gamma 2 (Gabrg2), transcript variant 1, mRNA [NM_008073] KLA 1.04 1.03 1.03 .97 .99 .98 1.03
ATP .97 1.00 1.05 1.00 1.01 1.01 1.01
KLA/ATP 1.01 .94 1.04 1.06 1.01 .95 1.02
Gabrg3
KLA  ATP  ATP+KLA
 NM_008074 gamma-aminobutyric acid (GABA-A) receptor, subunit gamma 3 (Gabrg3), mRNA [NM_008074] KLA .98 1.03 1.01 1.05 1.01 1.08 1.09
ATP 1.04 1.09 1.02 1.06 1.07 1.05 1.06
KLA/ATP 1.01 1.14 1.07 1.04 1.04 1.15 1.01
Gabrp
KLA  ATP  ATP+KLA
 NM_146017 gamma-aminobutyric acid (GABA-A) receptor, pi (Gabrp), mRNA [NM_146017] KLA 1.03 .97 .99 1.08 .98 1.08 1.00
ATP .95 1.04 1.03 .95 .95 .95 1.05
KLA/ATP .97 .98 .98 .98 .95 .94 .86
Gabrq
KLA  ATP  ATP+KLA
 NM_020488 gamma-aminobutyric acid (GABA-A) receptor, subunit theta (Gabrq), mRNA [NM_020488] KLA 1.00 .97 1.04 1.02 1.02 .88 .96
ATP 1.03 1.03 .99 .94 1.05 .94 .90
KLA/ATP .94 1.00 1.03 .93 .98 1.01 1.01
Gabrr1
KLA  ATP  ATP+KLA
 NM_008075 gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 (Gabrr1), mRNA [NM_008075] KLA 1.37 1.28 1.42 1.45 1.28 1.19 1.01
ATP .99 1.01 1.30 1.10 1.13 1.05 .80
KLA/ATP 1.25 1.36 1.40 1.29 1.16 1.00 .79
Gabrr2
KLA  ATP  ATP+KLA
 NM_008076 gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 (Gabrr2), mRNA [NM_008076] KLA 1.03 1.04 .99 1.02 1.05 .98 1.12
ATP 1.07 .98 1.00 1.08 1.04 .97 1.02
KLA/ATP 1.04 1.00 .94 .99 1.05 1.05 1.05
Gad1
KLA  ATP  ATP+KLA
 AK054554 10 days neonate olfactory brain cDNA, RIKEN full-length enriched library, clone:E530004P22 product:glutamic acid decarboxylase 1, full insert sequence. [AK054554] KLA 1.03 1.00 1.00 1.00 1.00 .98 1.10
ATP 1.03 .91 1.01 1.05 .99 .97 1.08
KLA/ATP .97 .99 .99 1.10 1.02 1.09 .96
Gad1
KLA  ATP  ATP+KLA
 NM_008077 glutamic acid decarboxylase 1 (Gad1), mRNA [NM_008077] KLA 1.03 .99 1.00 1.01 1.01 .97 .99
ATP 1.02 1.02 1.01 .99 1.02 1.03 .98
KLA/ATP .96 1.03 1.04 .99 .99 1.04 1.01
Gad2
KLA  ATP  ATP+KLA
 NM_008078 glutamic acid decarboxylase 2 (Gad2), mRNA [NM_008078] KLA 1.03 1.07 1.11 1.11 1.04 .99 1.07
ATP .97 .99 1.02 1.02 1.01 .95 .97
KLA/ATP 1.05 1.08 1.04 1.01 1.00 1.06 1.00
Gls2
KLA  ATP  ATP+KLA
 NM_001033264 glutaminase 2 (liver, mitochondrial) (Gls2), nuclear gene encoding mitochondrial protein, mRNA [NM_001033264] KLA 1.03 .98 1.02 .97 .98 .88 .80
ATP .94 1.01 1.04 1.08 1.26 1.20 .87
KLA/ATP .95 .98 1.15 1.02 1.29 .99 .87
Glul
KLA  ATP  ATP+KLA
 NM_008131 glutamate-ammonia ligase (glutamine synthetase) (Glul), mRNA [NM_008131] KLA .58 .54 .47 .41 .30 .31 .40
ATP .96 .99 1.46 2.55 2.16 2.88 1.34
KLA/ATP .57 .56 .83 1.52 1.27 1.20 .97
Glul
KLA  ATP  ATP+KLA
 X16314 gb|M.musculus mRNA for glutamine synthetase. [X16314] KLA .86 .95 .79 .87 .78 .99 .83
ATP .95 1.03 1.09 1.27 1.14 1.37 1.00
KLA/ATP .88 .97 .89 1.12 1.01 1.19 .91
Gnai1
KLA  ATP  ATP+KLA
 NM_010305 guanine nucleotide binding protein (G protein), alpha inhibiting 1 (Gnai1), mRNA [NM_010305] KLA .95 1.01 1.01 1.00 1.09 1.10 1.08
ATP 1.06 1.06 .99 1.15 1.02 .94 .99
KLA/ATP 1.02 1.04 .99 1.16 1.01 1.02 1.13
Gnai2
KLA  ATP  ATP+KLA
 NM_008138 guanine nucleotide binding protein (G protein), alpha inhibiting 2 (Gnai2), mRNA [NM_008138] KLA .74 .79 .82 .74 .91 .97 1.10
ATP 1.07 1.16 .78 1.12 .78 .48 .82
KLA/ATP .91 .81 .53 .80 .60 .68 .87
Gnai3
KLA  ATP  ATP+KLA
 NM_010306 guanine nucleotide binding protein (G protein), alpha inhibiting 3 (Gnai3), mRNA [NM_010306] KLA 1.23 1.24 1.14 1.06 .99 1.15 1.09
ATP .96 .93 .86 .64 1.34 2.02 1.35
KLA/ATP 1.20 1.24 .97 .76 1.21 1.62 1.17
Gnao1
KLA  ATP  ATP+KLA
 NM_001113384 guanine nucleotide binding protein, alpha O (Gnao1), transcript variant B, mRNA [NM_001113384] KLA .95 .98 1.03 1.00 1.02 1.02 .99
ATP .95 1.02 1.01 1.08 .99 .97 .95
KLA/ATP 1.05 1.04 1.10 .99 1.01 .98 1.03
Gnao1
KLA  ATP  ATP+KLA
 NM_010308 guanine nucleotide binding protein, alpha O (Gnao1), transcript variant A, mRNA [NM_010308] KLA .98 .96 1.00 .97 .96 .97 1.01
ATP 1.12 .99 1.05 .87 .97 1.02 1.01
KLA/ATP .93 1.00 .99 1.01 1.05 1.07 .98
Gnb1
KLA  ATP  ATP+KLA
 NM_008142 guanine nucleotide binding protein (G protein), beta 1 (Gnb1), mRNA [NM_008142] KLA 1.11 1.18 1.22 1.19 1.29 1.32 1.76
ATP 1.02 1.09 .84 .99 .97 .89 1.22
KLA/ATP 1.20 1.25 .85 1.01 .86 .91 1.57
Gnb2
KLA  ATP  ATP+KLA
 NM_010312 guanine nucleotide binding protein (G protein), beta 2 (Gnb2), mRNA [NM_010312] KLA .94 .98 .94 1.08 1.23 1.32 1.16
ATP 1.04 .96 .59 .64 .59 .76 1.18
KLA/ATP 1.02 .84 .62 .64 .61 .89 1.36
Gnb3
KLA  ATP  ATP+KLA
 NM_013530 guanine nucleotide binding protein (G protein), beta 3 (Gnb3), mRNA [NM_013530] KLA .99 1.00 .98 1.03 .94 .99 .96
ATP 1.01 1.02 .97 .95 1.01 .97 .92
KLA/ATP .99 1.02 1.02 .98 .99 .85 .99
Gnb4
KLA  ATP  ATP+KLA
 AK165084 2 days pregnant adult female ovary cDNA, RIKEN full-length enriched library, clone:E330002E21 product:guanine nucleotide binding protein, beta 4, full insert sequence [AK165084] KLA 4.61 4.10 4.23 2.41 2.25 1.59 .93
ATP 1.21 1.17 1.04 .81 2.92 1.50 1.03
KLA/ATP 5.86 6.56 3.60 1.68 5.62 3.00 1.37
Gnb4
KLA  ATP  ATP+KLA
 NM_013531 guanine nucleotide binding protein (G protein), beta 4 (Gnb4), mRNA [NM_013531] KLA 8.41 8.09 10.57 9.44 6.06 2.97 .92
ATP 1.07 1.04 1.09 .87 1.48 2.10 1.18
KLA/ATP 8.14 8.93 9.12 7.69 5.03 5.11 2.37
Gnb5
KLA  ATP  ATP+KLA
 NM_010313 guanine nucleotide binding protein (G protein), beta 5 (Gnb5), transcript variant 1, mRNA [NM_010313] KLA .68 .75 .67 .66 .53 .50 .65
ATP 1.03 1.08 1.09 1.14 .72 .54 .77
KLA/ATP .73 .70 .71 .73 .61 .65 .58
Gng10
KLA  ATP  ATP+KLA
 NM_025277 guanine nucleotide binding protein (G protein), gamma 10 (Gng10), mRNA [NM_025277] KLA .95 .95 .86 .83 .70 .53 .43
ATP .93 1.03 1.17 1.21 .97 .60 .52
KLA/ATP .84 .91 .93 .99 .79 .47 .24
Gng11
KLA  ATP  ATP+KLA
 NM_025331 guanine nucleotide binding protein (G protein), gamma 11 (Gng11), mRNA [NM_025331] KLA 1.30 1.26 1.44 1.54 1.26 1.42 1.90
ATP .88 .78 1.26 1.14 .90 .64 1.60
KLA/ATP 1.11 1.18 1.81 1.55 1.81 1.75 3.05
Gng12
KLA  ATP  ATP+KLA
 NM_025278 guanine nucleotide binding protein (G protein), gamma 12 (Gng12), mRNA [NM_025278] KLA 2.21 2.23 2.48 2.62 2.47 2.28 1.68
ATP 1.02 1.02 1.09 1.10 1.20 1.32 1.01
KLA/ATP 2.10 2.17 2.38 2.40 1.91 1.60 1.77
Gng13
KLA  ATP  ATP+KLA
 NM_022422 guanine nucleotide binding protein (G protein), gamma 13 (Gng13), mRNA [NM_022422] KLA 1.04 1.04 .94 1.00 1.00 1.05 .96
ATP 1.07 1.05 1.02 .94 .98 1.03 1.01
KLA/ATP 1.01 .99 1.05 1.01 1.01 .98 1.02
Gng2
KLA  ATP  ATP+KLA
 NM_010315 guanine nucleotide binding protein (G protein), gamma 2 (Gng2), transcript variant 1, mRNA [NM_010315] KLA .79 .81 .81 .82 .67 .57 .75
ATP 1.02 1.01 1.13 1.35 1.48 1.01 1.31
KLA/ATP .79 .86 .97 1.05 1.29 1.00 .84
Gng3
KLA  ATP  ATP+KLA
 NM_010316 guanine nucleotide binding protein (G protein), gamma 3 (Gng3), mRNA [NM_010316] KLA 1.00 .98 1.02 .95 .99 1.00 1.06
ATP .98 1.05 .99 1.03 1.05 1.03 .97
KLA/ATP 1.01 1.00 1.07 1.01 1.04 1.04 1.05
Gng4
KLA  ATP  ATP+KLA
 NM_010317 guanine nucleotide binding protein (G protein), gamma 4 (Gng4), mRNA [NM_010317] KLA 1.27 1.26 1.47 1.30 1.15 1.13 .82
ATP 1.05 .97 1.07 1.62 3.97 3.46 1.24
KLA/ATP 1.35 1.32 1.37 1.35 1.64 2.18 1.56
Gng5
KLA  ATP  ATP+KLA
 NM_010318 guanine nucleotide binding protein (G protein), gamma 5 (Gng5), mRNA [NM_010318] KLA .94 .84 .80 1.12 .98 1.11 1.29
ATP 1.07 1.01 1.07 1.05 1.17 1.52 1.01
KLA/ATP .83 .94 1.27 1.17 1.19 1.35 1.36
Gng7
KLA  ATP  ATP+KLA
 NM_001038655 guanine nucleotide binding protein (G protein), gamma 7 (Gng7), transcript variant 1, mRNA [NM_001038655] KLA .92 .96 .87 .91 .83 .98 .98
ATP 1.04 1.06 .98 .95 .81 .77 .75
KLA/ATP .97 .95 .81 .91 .79 .77 .81
Gng8
KLA  ATP  ATP+KLA
 NM_010320 guanine nucleotide binding protein (G protein), gamma 8 (Gng8), mRNA [NM_010320] KLA .93 .93 .95 .96 .90 .88 1.09
ATP .95 .90 1.01 .92 1.04 1.01 1.05
KLA/ATP .97 1.03 .99 .90 1.10 .99 1.04
Gngt1
KLA  ATP  ATP+KLA
 NM_010314 guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1 (Gngt1), mRNA [NM_010314] KLA 1.06 .99 .95 .98 1.03 1.10 .98
ATP .96 1.02 1.03 1.03 .94 1.06 .95
KLA/ATP .98 1.03 1.04 1.04 1.01 1.03 1.01
Gphn
KLA  ATP  ATP+KLA
 AK017831 8 days embryo whole body cDNA, RIKEN full-length enriched library, clone:5730552E08 product:inferred: RIKEN cDNA 5730552E08 gene, full insert sequence [AK017831] KLA 1.58 1.60 1.54 1.20 1.08 .93 1.08
ATP .98 1.01 1.02 1.20 .80 .71 .78
KLA/ATP 1.69 1.87 1.62 1.85 1.13 .79 .91
Gphn
KLA  ATP  ATP+KLA
 NM_172952 gephyrin (Gphn), mRNA [NM_172952] KLA 1.93 2.14 2.17 2.30 1.82 .98 1.08
ATP .98 1.12 1.12 1.15 .95 1.02 .81
KLA/ATP 1.89 2.07 2.14 2.08 1.52 .98 .94
Hap1
KLA  ATP  ATP+KLA
 NM_010404 huntingtin-associated protein 1 (Hap1), mRNA [NM_010404] KLA 2.10 2.03 2.71 2.59 2.99 2.38 1.20
ATP .96 .96 1.41 1.39 1.63 1.82 1.21
KLA/ATP 2.02 2.21 2.73 2.75 3.07 2.77 1.98
Kcnj6
KLA  ATP  ATP+KLA
 NM_001025585 potassium inwardly-rectifying channel, subfamily J, member 6 (Kcnj6), transcript variant Girk2B, mRNA [NM_001025585] KLA .97 .96 .95 .96 .98 .96 .95
ATP 1.00 .98 1.02 1.00 .98 .96 .97
KLA/ATP .98 .95 .99 .96 .98 .93 .96
Kcnj6
KLA  ATP  ATP+KLA
 NM_010606 potassium inwardly-rectifying channel, subfamily J, member 6 (Kcnj6), transcript variant Girk2A-1, mRNA [NM_010606] KLA .96 1.03 .97 .98 .97 .99 1.07
ATP 1.08 .99 .99 1.05 .96 1.04 .97
KLA/ATP 1.01 .92 1.03 1.03 1.04 1.03 1.08
Mm.19418
3
KLA  ATP  ATP+KLA
 82879023 Unknown KLA 2.30 2.08 1.50 1.10 .91 .84 .68
ATP .98 .92 1.09 1.04 1.56 1.73 .87
KLA/ATP 2.07 2.14 1.87 1.24 1.31 1.17 .76
Mm.29656
0
KLA  ATP  ATP+KLA
 34328321 Unknown KLA 1.41 1.37 1.50 1.48 1.35 1.43 1.21
ATP 1.00 1.08 1.22 1.42 1.23 1.22 1.23
KLA/ATP 1.41 1.48 1.57 1.61 1.50 1.56 1.51
Mm.30102
KLA  ATP  ATP+KLA
 142348692 Unknown KLA 1.04 1.04 .97 1.07 1.02 .93 .90
ATP 1.06 .98 1.13 1.06 1.30 1.19 .78
KLA/ATP .94 1.05 1.13 1.05 1.24 1.12 .84
Mm.41137
KLA  ATP  ATP+KLA
 148747308 Unknown KLA 1.03 1.00 .95 .92 1.04 .98 .96
ATP 1.02 .98 .98 .90 .95 .92 1.07
KLA/ATP .91 .89 1.01 .95 1.00 .96 .99
Mm.44046
5
KLA  ATP  ATP+KLA
 164607131 Unknown KLA .65 .56 .59 .51 .33 .20 .24
ATP 1.07 .90 1.30 2.88 3.61 4.46 1.07
KLA/ATP .60 .59 .95 2.38 2.99 2.31 .37
Mm.44050
5
KLA  ATP  ATP+KLA
 84579905 Unknown KLA 1.03 .96 .90 1.03 .94 1.15 1.23
ATP .88 .91 1.15 1.18 1.17 1.31 1.02
KLA/ATP .87 .97 1.19 1.18 1.36 1.34 1.25
Mm.4424
KLA  ATP  ATP+KLA
 110225367 Unknown KLA .99 .93 1.01 1.02 1.00 .92 1.00
ATP .98 1.03 3.11 1.13 1.19 1.03 1.11
KLA/ATP .95 .97 .97 .96 .93 1.01 .99
Nsf
KLA  ATP  ATP+KLA
 NM_008740 N-ethylmaleimide sensitive fusion protein (Nsf), mRNA [NM_008740] KLA .84 .83 .76 .70 .78 .80 .94
ATP 1.14 1.15 .99 1.08 .95 .96 1.19
KLA/ATP .93 .90 .80 .85 .72 .80 1.17
Plcl1
KLA  ATP  ATP+KLA
 AK048715 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230017K02 product:similar to CDNA FLJ13484 FIS, CLONE PLACE1003888, WEAKLY SIMILAR TO 1-PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE PHOSPHODIESTERASE DELTA 1 (EC 3.1.4.11 KLA .93 .91 .90 .86 .92 .93 1.00
ATP .95 1.04 .91 .84 .84 .83 .80
KLA/ATP .97 .92 .93 .88 .79 .76 .73
Prkaca
KLA  ATP  ATP+KLA
 NM_008854 protein kinase, cAMP dependent, catalytic, alpha (Prkaca), mRNA [NM_008854] KLA .71 .74 .72 .70 .72 .84 .85
ATP 1.05 .98 .89 .92 .76 .60 1.02
KLA/ATP .79 .74 .55 .65 .60 .65 .93
Prkacb
KLA  ATP  ATP+KLA
 NM_011100 protein kinase, cAMP dependent, catalytic, beta (Prkacb), mRNA [NM_011100] KLA .69 .70 .66 .58 .51 .55 .59
ATP 1.02 1.19 .97 1.01 .69 .38 .56
KLA/ATP .72 .73 .57 .62 .47 .41 .45
Prkca
KLA  ATP  ATP+KLA
 NM_011101 protein kinase C, alpha (Prkca), mRNA [NM_011101] KLA 1.00 .96 .94 .95 .95 .89 .96
ATP 1.00 1.03 .91 .94 .82 .87 1.13
KLA/ATP 1.02 .95 .91 .86 .78 .84 .94
Prkcb1
KLA  ATP  ATP+KLA
 NM_008855 protein kinase C, beta 1 (Prkcb1), mRNA [NM_008855] KLA .92 .95 .93 .78 .77 1.08 1.83
ATP 1.03 1.12 1.09 1.23 .90 2.08 .96
KLA/ATP .98 .99 .82 .89 .62 1.01 1.08
Prkcc
KLA  ATP  ATP+KLA
 NM_011102 protein kinase C, gamma (Prkcc), mRNA [NM_011102] KLA 1.02 1.04 1.11 1.04 .96 1.02 1.05
ATP .98 .98 1.05 1.03 1.08 .96 .95
KLA/ATP 1.21 1.16 1.09 1.07 1.04 .98 .93
Prkx
KLA  ATP  ATP+KLA
 NM_016979 protein kinase, X-linked (Prkx), mRNA [NM_016979] KLA 3.61 3.79 4.67 4.66 4.85 4.19 1.43
ATP .98 .90 .63 .61 1.12 1.90 1.29
KLA/ATP 3.56 3.36 2.62 2.06 2.26 2.87 2.31
Slc12a5
KLA  ATP  ATP+KLA
 NM_020333 solute carrier family 12, member 5 (Slc12a5), mRNA [NM_020333] KLA 1.01 .99 .97 .99 .94 1.03 1.36
ATP .92 .87 1.25 1.10 .81 .69 1.01
KLA/ATP .87 .97 1.22 1.01 1.06 .70 .78
Slc32a1
KLA  ATP  ATP+KLA
 NM_009508 solute carrier family 32 (GABA vesicular transporter), member 1 (Slc32a1), mRNA [NM_009508] KLA 1.11 1.01 1.06 1.10 1.07 1.05 1.04
ATP 1.03 .97 1.11 1.10 1.52 1.52 1.08
KLA/ATP 1.10 1.12 1.09 1.17 1.36 1.50 1.10
Slc38a1
KLA  ATP  ATP+KLA
 AK162429 12 days embryo embryonic body between diaphragm region and neck cDNA, RIKEN full-length enriched library, clone:9430020E10 product:hypothetical protein, full insert sequence [AK162429] KLA .93 .80 .66 .47 .37 .57 .84
ATP .92 .84 .94 1.58 1.58 .90 .50
KLA/ATP .87 .70 .62 .86 1.20 .96 .52
Slc38a1
KLA  ATP  ATP+KLA
 NM_134086 solute carrier family 38, member 1 (Slc38a1), mRNA [NM_134086] KLA 1.24 1.07 1.03 .84 .66 .71 .91
ATP .90 .83 1.17 1.64 1.92 1.39 .90
KLA/ATP 1.12 1.02 1.20 1.25 1.65 1.27 .99
Slc38a2
KLA  ATP  ATP+KLA
 AK164568 13 days embryo heart cDNA, RIKEN full-length enriched library, clone:D330050A21 product:solute carrier family 38, member 2, full insert sequence [AK164568] KLA .49 .44 .31 .39 .58 .67 .87
ATP 1.52 1.82 5.27 8.64 3.25 1.48 1.13
KLA/ATP .47 .68 1.28 2.77 2.02 .86 .76
Slc38a2
KLA  ATP  ATP+KLA
 NM_175121 solute carrier family 38, member 2 (Slc38a2), mRNA [NM_175121] KLA .45 .46 .38 .34 .33 .52 .73
ATP 1.04 1.22 1.93 5.44 5.96 3.34 1.39
KLA/ATP .45 .48 .58 1.67 2.62 1.71 .86
Slc38a3
KLA  ATP  ATP+KLA
 NM_023805 solute carrier family 38, member 3 (Slc38a3), mRNA [NM_023805] KLA 1.18 1.02 1.01 1.03 1.04 1.04 .99
ATP 1.01 .98 1.11 1.06 .99 1.05 1.06
KLA/ATP 1.02 1.03 1.15 1.07 1.04 .96 1.06
Slc38a5
KLA  ATP  ATP+KLA
 NM_172479 solute carrier family 38, member 5 (Slc38a5), mRNA [NM_172479] KLA 1.00 .96 .98 .96 1.02 1.04 1.06
ATP .99 1.02 1.06 1.07 1.01 1.04 1.04
KLA/ATP 1.04 1.00 1.04 1.06 1.12 1.04 1.07
Slc6a1
KLA  ATP  ATP+KLA
 NM_178703 solute carrier family 6 (neurotransmitter transporter, GABA), member 1 (Slc6a1), mRNA [NM_178703] KLA 1.02 .93 1.06 1.00 .99 .96 1.01
ATP 1.03 .95 .94 .93 .97 .97 .98
KLA/ATP 1.02 1.10 .93 1.01 1.08 1.02 .92
Slc6a13
KLA  ATP  ATP+KLA
 NM_144512 solute carrier family 6 (neurotransmitter transporter, GABA), member 13 (Slc6a13), mRNA [NM_144512] KLA 1.04 1.02 1.01 1.02 1.08 1.21 2.95
ATP .99 1.00 1.02 1.08 1.02 1.17 2.70
KLA/ATP 1.11 1.04 1.06 1.20 1.32 1.28 3.01
Src
KLA  ATP  ATP+KLA
 NM_009271 Rous sarcoma oncogene (Src), transcript variant 1, mRNA [NM_009271] KLA 6.99 7.23 7.54 5.99 5.34 3.39 3.00
ATP 1.02 1.06 1.06 2.08 4.41 5.03 3.97
KLA/ATP 7.44 7.51 5.48 6.24 4.86 5.86 7.90
Trak2
KLA  ATP  ATP+KLA
 NM_172406 trafficking protein, kinesin binding 2 (Trak2), mRNA [NM_172406] KLA .94 1.01 1.01 .90 .86 .85 .98
ATP 1.05 1.04 1.02 .95 1.07 1.14 1.01
KLA/ATP 1.04 .93 .84 .79 .80 .95 .93